Literature DB >> 6699861

Continuous ambulatory peritoneal dialysis in systemic amyloidosis and end-stage renal disease.

M J Browning, R A Banks, P Harrison, C R Tribe, C T Fraley, G Zachary, C Mackenzie.   

Abstract

Three patients with end-stage renal failure complicating systemic amyloidosis have been treated with continuous ambulatory peritoneal dialysis for periods of 10, 14 and 18 months respectively. In each case satisfactory control of uraemia and fluid balance has been achieved.

Entities:  

Mesh：

Year:  1984        PMID： 6699861      PMCID： PMC1439866          DOI： 10.1177/014107688407700306

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


  9 in total

1.  Steroidal sulphur compounds. Part XII. Regiospecific formation of steroidal olefins by thermolysis of sulphoxides.

Authors:  D N Jones; A C Edmonds; S D Knox
Journal:  J Chem Soc Perkin 1       Date:  1976

2.  Renal transplantation in amyloidosis.

Authors:  B Kuhlbäck; H Falck; T Törnroth; M Wallenius; B L Lindström; A Pasternack
Journal:  Acta Med Scand       Date:  1979

3.  Transplantation for renal amyloidosis.

Authors:  C L Kennedy; J E Castro
Journal:  Transplantation       Date:  1977-11       Impact factor: 4.939

4.  Renal transplantation in two cases of amyloidosis.

Authors:  A S Cohen; A B Bricetti; J T Harrington; J A Mannick
Journal:  Lancet       Date:  1971-09-04       Impact factor: 79.321

5.  Chronic peritoneal dialysis in a patient with primary amyloidosis, renal failure, and factor X deficiency.

Authors:  W J Stone; D L Latos; P G Lankford; A S Baker
Journal:  South Med J       Date:  1978-07       Impact factor: 0.954

6.  Amyloidosis: review of 236 cases.

Authors:  R A Kyle; E D Bayrd
Journal:  Medicine (Baltimore)       Date:  1975-07       Impact factor: 1.889

7.  Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.

Authors:  J R Wright; E Calkins; R L Humphrey
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

8.  Renal involvement in systemic amyloidosis.

Authors:  M Browning; R Banks; C Tribe; P Bacon; P Hollingworth; C Kingswood; J Poulding; P Harrison; J C Mackenzie
Journal:  Proc Eur Dial Transplant Assoc       Date:  1983

9.  Continuous ambulatory peritoneal dialysis (CAPD) on Merseyside--cost/cost effectiveness.

Authors:  S F Beardsworth; H J Goldsmith
Journal:  Health Trends       Date:  1982-11
  9 in total
  5 in total

1.  Role of amyloidosis in determining the prognosis of dialyzed patients with rheumatoid arthritis.

Authors:  Toru Sanai; Fumio Nanishi; Masatoshi Nagata; Tadashi Hirano; Eiichi Suematsu; Yukio Esaki; Hisaaki Miyahara; Mitsuo Iida
Journal:  Rheumatol Int       Date:  2006-09-30       Impact factor: 2.631

2.  Replacement therapy in end-stage renal amyloidosis.

Authors:  R A Banks; C R Tribe; H J White; P R Harrison; J C Mackenzie
Journal:  J R Soc Med       Date:  1985-07       Impact factor: 5.344

3.  CAPD in end-stage renal amyloidosis.

Authors:  R A Banks; M J Browning; P Harrison; J C Mackenzie
Journal:  J R Soc Med       Date:  1984-12       Impact factor: 5.344

4.  Renal transplantation in amyloid nephropathy.

Authors:  P Heering; B Kutkuhn; H Frenzel; R P Linke; B Grabensee
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

5.  A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis.

Authors:  K Dohmen; M Nagano; R Iwakiri; Y Yamano; Y Kikuchi; M Mizoguchi; Y Iwata; Y Mori; H Ishibashi
Journal:  Gastroenterol Jpn       Date:  1991-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.